You are currently viewing archive.bio.org. Head to our home page to check out our fresh new look!

BIO Statement on Initial Decision in Myriad Genetics Lawsuit

<p>
BIO is pleased that the Court dismissed the far-reaching claims regarding the constitutionality of patenting gene-based inventions. Disputed allegations that patents supposedly stifle research or impede patient access were explicitly excluded from consideration.</p>

WASHINGTON, D.C. (March 30, 2010) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the decision issued yesterday in the lawsuit brought by the American Civil Liberties Union (ACLU) against Myriad Genetics in the U.S. District Court in the Southern District of New York:  

“As explained in the ruling yesterday, the District Court’s determination is only a preliminary step in the legal process that does not affect how the U.S. Patent and Trademark Office (PTO) evaluates patent applications relating to DNA-based inventions. 

“BIO is pleased that the Court dismissed the far-reaching claims regarding the constitutionality of patenting gene-based inventions. Disputed allegations that patents supposedly stifle research or impede patient access were explicitly excluded from consideration. And the invalidation of the diagnostic method claims was done under a Federal Circuit opinion (In Re Bilski) which will soon be clarified further by the Supreme Court.

“From the mass production of life-saving medicines by cell cultures to the screening of our blood supply for life-threatening viruses, patented DNA molecules have been put to countless uses that have benefited society. Preparations of isolated and purified DNA molecules, which alone can be put to use in these ways, are patentable because they are fundamentally different from anything that occurs in nature.”

BIO’s amicus brief in the Myriad Genetics case is available at http://bio.org/ip/amicus/documents/BIOAmicusBriefACLU-Myriad12-09.pdf and the amicus brief for the Bilski case is available at http://bio.org/ip/amicus/documents/08-964tsacBiotechnologyIndustryOrganizationetal.pdf.  Additional background materials on gene patenting are available at http://bio.org/ip/genepat

 

Upcoming BIO Events

BIO Intellectual Property Counsels Spring Conference and Committee Meeting
April 19-21, 2010
New Orleans, LA 

Partnering for Global Health
May 3, 2010
Chicago, IL

BIO International Convention
May 3-6, 2010
Chicago, IL

2010 BIO Human Resources Conference
May 4-7, 2010
Chicago, IL 

World Congress on Industrial Biotechnology and Bioprocessing
June 27-30, 2010
Washington, DC

BIO India
September 21 - 22, 2010
Hyderabad, India

 

BIO’s Livestock Biotechnology Summit
September 28-30, 2010,
Sioux Falls, SD

###